These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23829620)

  • 1. Can IL-6 blockade rectify imbalance between Tregs and Th17 cells?
    Tanaka T
    Immunotherapy; 2013 Jul; 5(7):695-7. PubMed ID: 23829620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patients.
    Pesce B; Soto L; Sabugo F; Wurmann P; Cuchacovich M; López MN; Sotelo PH; Molina MC; Aguillón JC; Catalán D
    Clin Exp Immunol; 2013 Mar; 171(3):237-42. PubMed ID: 23379428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis.
    Samson M; Audia S; Janikashvili N; Ciudad M; Trad M; Fraszczak J; Ornetti P; Maillefert JF; Miossec P; Bonnotte B
    Arthritis Rheum; 2012 Aug; 64(8):2499-503. PubMed ID: 22488116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion.
    Guggino G; Giardina AR; Raimondo S; Giardina G; Sireci G; Dieli F; Peralta M; Alessandro R; Triolo G; Ciccia F
    Clin Exp Rheumatol; 2014; 32(1):77-81. PubMed ID: 24429356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
    Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
    Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The balance between Foxp3 and Ror-γt expression in peripheral blood is altered by tocilizumab and abatacept in patients with rheumatoid arthritis.
    Tada Y; Ono N; Suematsu R; Tashiro S; Sadanaga Y; Tokuda Y; Ono Y; Nakao Y; Maruyama A; Ohta A; Koarada S
    BMC Musculoskelet Disord; 2016 Jul; 17():290. PubMed ID: 27421886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of interleukin-6 signalling and its therapeutic blockage in skewing the T cell balance in rheumatoid arthritis.
    Schinnerling K; Aguillón JC; Catalán D; Soto L
    Clin Exp Immunol; 2017 Jul; 189(1):12-20. PubMed ID: 28369786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy.
    McGovern JL; Nguyen DX; Notley CA; Mauri C; Isenberg DA; Ehrenstein MR
    Arthritis Rheum; 2012 Oct; 64(10):3129-38. PubMed ID: 22674488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
    Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
    Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of interleukin-6 signal inhibition on Treg subpopulations and association of Tregs with clinical outcomes in rheumatoid arthritis.
    Yoshida H; Magi M; Tamai H; Kikuchi J; Yoshimoto K; Otomo K; Matsumoto Y; Noguchi-Sasaki M; Takeuchi T; Kaneko Y
    Rheumatology (Oxford); 2024 Sep; 63(9):2515-2524. PubMed ID: 38530780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response.
    Kikuchi J; Hashizume M; Kaneko Y; Yoshimoto K; Nishina N; Takeuchi T
    Arthritis Res Ther; 2015 Jan; 17(1):10. PubMed ID: 25604867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis.
    Li S; Wu Z; Li L; Liu X
    Med Sci Monit; 2016 Jun; 22():2113-8. PubMed ID: 27322646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-3 polyunsaturated fatty acids restore Th17 and Treg balance in collagen antibody-induced arthritis.
    Kim JY; Lim K; Kim KH; Kim JH; Choi JS; Shim SC
    PLoS One; 2018; 13(3):e0194331. PubMed ID: 29543869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic targeting of the interleukin-6 receptor.
    Tanaka T; Narazaki M; Kishimoto T
    Annu Rev Pharmacol Toxicol; 2012; 52():199-219. PubMed ID: 21910626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic Transdifferentiation of Th17 Cells Contribute to Perpetuation of Rheumatoid Arthritis during Anti-TNF Treatment.
    Andersson KM; Cavallini NF; Hu D; Brisslert M; Cialic R; Valadi H; Erlandsson MC; Silfverswärd S; Pullerits R; Kuchroo VK; Weiner HL; Bokarewa MI
    Mol Med; 2015 Jun; 21(1):536-43. PubMed ID: 26062018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrandrine ameliorates collagen-induced arthritis in mice by restoring the balance between Th17 and Treg cells via the aryl hydrocarbon receptor.
    Yuan X; Tong B; Dou Y; Wu X; Wei Z; Dai Y
    Biochem Pharmacol; 2016 Feb; 101():87-99. PubMed ID: 26640276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An expanded population of pathogenic regulatory T cells in giant cell arteritis is abrogated by IL-6 blockade therapy.
    Miyabe C; Miyabe Y; Strle K; Kim ND; Stone JH; Luster AD; Unizony S
    Ann Rheum Dis; 2017 May; 76(5):898-905. PubMed ID: 27927642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAK2-STAT3 blockade by AG490 suppresses autoimmune arthritis in mice via reciprocal regulation of regulatory T Cells and Th17 cells.
    Park JS; Lee J; Lim MA; Kim EK; Kim SM; Ryu JG; Lee JH; Kwok SK; Park KS; Kim HY; Park SH; Cho ML
    J Immunol; 2014 May; 192(9):4417-24. PubMed ID: 24688026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on relationship among apoptosis rates, number of peripheral T cell subtypes and disease activity in rheumatoid arthritis.
    Ji L; Geng Y; Zhou W; Zhang Z
    Int J Rheum Dis; 2016 Feb; 19(2):167-71. PubMed ID: 24618356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti‑inflammatory effects of oxymatrine on rheumatoid arthritis in rats via regulating the imbalance between Treg and Th17 cells.
    Ma A; Yang Y; Wang Q; Wang Y; Wen J; Zhang Y
    Mol Med Rep; 2017 Jun; 15(6):3615-3622. PubMed ID: 28440447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.